These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11361530)

  • 1. Industry, governments, and nonprofits worldwide join effort to develop AIDS vaccine.
    AIDS Patient Care STDS; 1996 Oct; 10(5):310-1. PubMed ID: 11361530
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinton sets goal of having an AIDS vaccine in 10 years.
    AIDS Policy Law; 1997 Jun; 12(11):3. PubMed ID: 11364387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fostering partnerships for vaccine development: a delicate fabric.
    Douglas RG
    Bull N Y Acad Med; 1996; 73(1):113-23. PubMed ID: 8804744
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug industry and neglected diseases].
    Flaten O; Korsvold J
    Tidsskr Nor Laegeforen; 2007 Feb; 127(3):319. PubMed ID: 17279114
    [No Abstract]   [Full Text] [Related]  

  • 5. Private industry, academia team up on HIV vaccine.
    Sweeney R; Lapp T
    Am Fam Physician; 2000 Aug; 62(3):483. PubMed ID: 10950207
    [No Abstract]   [Full Text] [Related]  

  • 6. An AIDS vaccine for all the world. Interview by Matthew O'Rourke.
    Berkley S
    AIDS Clin Care; 1999 Jul; 11(7):55-7, 62. PubMed ID: 11366434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Funding support lacking in search for HIV vaccine.
    AIDS Alert; 1999 Jan; 14(1):5-7. PubMed ID: 11366091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicine. The need for a global HIV vaccine enterprise.
    Klausner RD; Fauci AS; Corey L; Nabel GJ; Gayle H; Berkley S; Haynes BF; Baltimore D; Collins C; Douglas RG; Esparza J; Francis DP; Ganguly NK; Gerberding JL; Johnston MI; Kazatchkine MD; McMichael AJ; Makgoba MW; Pantaleo G; Piot P; Shao Y; Tramont E; Varmus H; Wasserheit JN
    Science; 2003 Jun; 300(5628):2036-9. PubMed ID: 12829768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Caregivers for the world. Nursing and cooperation in the non-government organizations for development].
    Mejías i Sendra JJ
    Rev Enferm; 1998 Dec; 21(244):37-41. PubMed ID: 10076466
    [No Abstract]   [Full Text] [Related]  

  • 10. Global health. Public-private partnerships proliferate.
    Cohen J
    Science; 2006 Jan; 311(5758):167. PubMed ID: 16410497
    [No Abstract]   [Full Text] [Related]  

  • 11. The International AIDS Vaccine Initiative.
    Berkley S
    J Int Assoc Physicians AIDS Care; 1997 Nov; 3(11):30-4. PubMed ID: 11364811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gore offers to help drug companies pursue research.
    AIDS Policy Law; 1996 Mar; 11(4):2. PubMed ID: 11363414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advocacy group sees little progress toward an HIV vaccine.
    AIDS Policy Law; 1998 May; 13(10):1, 8-9. PubMed ID: 11365444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global perspectives on vaccine financing.
    Berman S; Giffin RB
    Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine development moves to front burner.
    AIDS Alert; 1997 Mar; 12(3):32-3. PubMed ID: 11364191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-8 endorses new global HIV vaccine enterprise.
    Bull World Health Organ; 2004 Jul; 82(7):557. PubMed ID: 15500292
    [No Abstract]   [Full Text] [Related]  

  • 17. Market incentives, human lives, and AIDS vaccines.
    Craddock S
    Soc Sci Med; 2007 Mar; 64(5):1042-56. PubMed ID: 17113203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenges of an HIV vaccine enterprise.
    Wolf H
    Science; 2004 Feb; 303(5662):1294-7; author reply 1294-7. PubMed ID: 14991961
    [No Abstract]   [Full Text] [Related]  

  • 19. A major initiative to step up efforts against sleeping sickness.
    J Adv Nurs; 2001 Nov; 36(3):327-8. PubMed ID: 11686747
    [No Abstract]   [Full Text] [Related]  

  • 20. Economic obstacles to the optimal utilization of an AIDS vaccine.
    Russell PK
    J Int Assoc Physicians AIDS Care; 1997 Sep; 3(9):31-3. PubMed ID: 11364712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.